Kalbe Farma 9-Month Net Income Rises to 1.1t Rupiah Vs Year Ago

PT Kalbe Farma’s January through September unaudited net income rose to 1.07 trillion rupiah from 902 billion rupiah in the same period a year earlier, the Indonesian pharmaceutical company said in a statement to the stock exchange.

To contact the reporter on this story: Femi Adi in Jakarta at fadi1@bloomberg.net

To contact the editor responsible for this story: Andrew Janes at ajanes@bloomberg.net

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.